Identification of host cell respiratory tract cell gene expression and epigenetic pattern after human SARS-CoV-2 infection (COVID-19)

Identification of host cell respiratory tract cell gene expression and epigenetic pattern after human SARS-CoV-2 infection (COVID-19) - SC2

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021134

Enrollment

Registered

2020-03-19

Start date

2020-03-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J12.8

Interventions

Group 1: no or mild symptoms of common cold, SARS-CoV-2 negative Group 2: mild COVID-19 Group 3: severe COVID-19 Group 4: severe viral pneumonia, SARS-CoV-2 negative

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: see study arms

Exclusion criteria

Exclusion criteria: minor

Design outcomes

Primary

Measure	Time frame
genetic and epigenetic risk profiles	—

Countries

Germany

Contacts

Public ContactSven Laudi

Klinik für Anästhesiologie und Intensivtherapie; Universitätsklinikum Leipzig

anaesthesie@medizin.uni-leipzig.de+49 341 97 17700

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026